EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Development of a simplified population pharmacokinetic–pharmacodynamic framework for exposure-informed risk stratification of neutropenia during amrubicin treatment

Yoshinori Makino, Takanori Ogawa, Reiko Makihara-Ando, Naomi Sakiyama, Masahito Yamazaki, Chizuru Naito, Hiroki Takayama, Genji Ueda, Shunsuke Kohyama, Maki Todo, Yasuhiro Kuwata, Masataka Hirasaki und 1 weitere

Cancer Chemotherapy and Pharmacology · 28.07.2026 · 96 (1)

DOI: 10.1007/s00280-026-04931-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, online erschienen am 28.07.2026. Verfasst von Yoshinori Makino und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Cancer Genomics, Department of Pharmacy, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka-shi, S…. Hauptthemen laut MEDLINE: Anthracyclines, Neutropenia, Antineoplastic Agents, Models, Biological. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Saitama Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnthracyclinesNeutropeniaAntineoplastic AgentsModels, BiologicalHumansRisk AssessmentBayes TheoremLung NeoplasmsFemaleSmall Cell Lung CarcinomaMale

Stichwörter der Autor:innen

AmrubicinNeutropeniaPopulation pharmacokinetic–pharmacodynamic modelSmall cell lung cancerSupportive care

Substanzen

amrubicinAnthracyclinesAntineoplastic Agentsamrubicinol

Autor:innen und Institutionen

  • Department of Clinical Cancer Genomics, Department of Pharmacy, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka-shi, Saitama, 350-1298, Japan. ymakino@saitama-med.ac.jp.
  • Department of Pharmacy, Saitama Medical University International Medical Center, 1397-1 Yamane, Hidaka-shi, Saitama, 350-1298, Japan. ymakino@saitama-med.ac.jp.
  • Cartara G.K, Toranomon 4-chome MT Building II, Floor 9, 4-2-12 Toranomon, Minato-ku, Tokyo, Japan.
  • Graduate School of Pharmaceutical Science, Showa Medical University, Tokyo, Japan.
  • Sanofi K.K, Tokyo, Japan.
  • Department of Pharmacy, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

Förderung

  • Saitama Medical University

Zitieren

APA

Makino, Y., Ogawa, T., Makihara-Ando, R., Sakiyama, N., Yamazaki, M., Naito, C., Takayama, H., Ueda, G., Kohyama, S., Todo, M., Kuwata, Y., Hirasaki, M., & Hamaguchi, T. (2026). Development of a simplified population pharmacokinetic–pharmacodynamic framework for exposure-informed risk stratification of neutropenia during amrubicin treatment. Cancer Chemotherapy and Pharmacology, 96(1). https://doi.org/10.1007/s00280-026-04931-8

Vancouver

Makino Y, Ogawa T, Makihara-Ando R, Sakiyama N, Yamazaki M, Naito C, et al. Development of a simplified population pharmacokinetic–pharmacodynamic framework for exposure-informed risk stratification of neutropenia during amrubicin treatment. Cancer Chemotherapy and Pharmacology. 2026;96(1). doi:10.1007/s00280-026-04931-8

BibTeX
@article{Makino2026,
  author = {Makino, Yoshinori and Ogawa, Takanori and Makihara-Ando, Reiko and Sakiyama, Naomi and Yamazaki, Masahito and Naito, Chizuru and Takayama, Hiroki and Ueda, Genji and Kohyama, Shunsuke and Todo, Maki and Kuwata, Yasuhiro and Hirasaki, Masataka and Hamaguchi, Tetsuya},
  title = {Development of a simplified population pharmacokinetic–pharmacodynamic framework for exposure-informed risk stratification of neutropenia during amrubicin treatment},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2026},
  volume = {96},
  number = {1},
  doi = {10.1007/s00280-026-04931-8}
}
Kostenlos starten →